Strong Procedure Growth
Da Vinci procedure growth in the quarter was 17%, with notable performance in general surgery in the U.S. and regional performance in India, Korea, and the U.K.
Record System Placements
367 da Vinci systems were placed in Q1 2025, a 17% increase from the previous year, including strong performance in the U.S.
Revenue Increase
First quarter revenue was $2.25 billion, a 19% increase over the previous year.
Ion and SP Segment Growth
Ion procedures grew 58%, while SP procedures grew 94%, showcasing strong adoption in both segments.
Expansion and New Facilities
Opened two new facilities in Sunnyvale, supporting manufacturing and R&D for da Vinci and Ion systems.